C

CRISPR Therapeutics

Zug, Switzerland Founded 2013 NASDAQ: CRSP
Gene Therapy Delivery Cell Therapy Nano DNA Nanotechnology Synthetic Biology Nano-Bio Nanomedicine

About

CRISPR-based gene editing therapeutics for blood disorders and cancer

Company Details

Type
public
Employees
700+
Funding
Public

Key Products

  • Casgevy
  • CTX110
  • Gene Editing Platform
Visit Website

Related Companies

N

NanoString Technologies

Seattle, United States

N

Nanobiotix

Paris, France

A

Arrowhead Research

Pasadena, United States

B

BIND Therapeutics

Cambridge, United States